United States · FDA National Drug Code directory
Albendazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-452_370b6498-30f2-48a4-f32a-9ee671cf294e
- Product NDC
- 43598-452
- Form
- TABLET, FILM COATED
- Composition / generic term
- Albendazole
- Labeler
- Dr.Reddys Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210126
- Source listing expiry
- 20261231
Source-listed ingredients
- ALBENDAZOLE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET, FILM COATED in 1 BOTTLE (43598-452-02) · 43598-452-02
- 1 BLISTER PACK in 1 CARTON (43598-452-17) / 8 TABLET, FILM COATED in 1 BLISTER PACK · 43598-452-17
- 28 TABLET, FILM COATED in 1 BOTTLE (43598-452-63) · 43598-452-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →